Loading clinical trials...
Loading clinical trials...
A Dose Escalation and Dose Expansion Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma - CEP-2
Conditions
Interventions
NOX66
NOX66
+3 more
Locations
4
United States
City of Hope
Duarte, California, United States
Mayo Clinic Florida - Oncology
Jacksonville, Florida, United States
Mayo Clinic
Rochester, Minnesota, United States
Site name Washington University School of Medicine in Saint Louis
St Louis, Missouri, United States
Start Date
February 11, 2022
Primary Completion Date
May 1, 2023
Completion Date
May 26, 2023
Last Updated
January 6, 2025
NCT05099666
NCT00538239
Lead Sponsor
Noxopharm Limited
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions